| 1 |
34736512 | Secreted indicators of androgen receptor activity in breast cancer pre-clinical models. | 2021 Nov 4 |
3 |
| 2 |
21809344 | Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation. | 2012 May |
3 |
| 3 |
21430968 | A survey: Precepts and practices in drug use indicators at Government Healthcare Facilities: A Hospital-based prospective analysis. | 2011 Jan |
1 |
| 4 |
10882017 | Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: synthesis and biological evaluation. | 2000 May |
1 |
| 5 |
10402478 | Regulation of GCDFP-15 expression in human mammary cancer cells. | 1999 Aug |
2 |
| 6 |
9111629 | Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters. | 1997 Apr |
1 |
| 7 |
8865161 | Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. | 1996 Jul 23 |
1 |
| 8 |
7558422 | Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. | 1995 Sep 15 |
3 |
| 9 |
7927949 | Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells. | 1994 Nov 1 |
1 |
| 10 |
2626033 | Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. | 1989 |
2 |
| 11 |
2725533 | Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. | 1989 Apr |
3 |
| 12 |
3667631 | Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D. | 1987 Nov 5 |
1 |